Nanoparticulate core shell systems and the use thereof in pharmaceutical and cosmetic preparation

1. A process for preparing a nano-particulate preparation of a pharmaceutical or cosmetic active ingredient with a core/shell structure, in which an X-ray amorphous active ingredient is present in the core together with one or more copolymers of acrylates, methacrylates, methacrylic acid or acrylic acid, and the shell consists of a stabilizing coating matrix,

the process comprising mixing an active ingredient/polymer solution or precipitate with an aqueous solution of a polymeric coating material continuously in a mixing chamber by spraying the two components as a compact jet into a mixing chamber,

wherein said polymeric coating material is selected from the group consisting of gelatin, chitosan, alginates, casein, caseinates, and homopolymers of acrylic acid,

wherein the particle size of the core/shell structure is in the range of 0.05 to 0.9 μm, and

wherein the core of the preparation has at least two separate phases.

2. The process as claimed in claim 1 , wherein one phase of the core consists of amorphous particles of the active ingredient, and the other phase comprises a molecular dispersion of the active ingredient in a polymer matrix.

3. The process as claimed in claim 1 , wherein one phase of the core consists of amorphous active ingredient, and the other phase being comprises a polymer matrix free of active ingredient.

4. The process as claimed in claim 1 , wherein the core polymers are suitable for pharmaceutical and cosmetic applications and are insoluble or only partly soluble in water.

5. A process for preparing a nano-particulate preparation of a pharmaceutical or cosmetic active ingredient with a core/shell structure, in which an X-ray amorphous active ingredient is present in the core together with one or more copolymers of acrylates, methacrylates, methacrylic acid or acrylic acid, and the shell consists of a stabilizing coating matrix,

the process comprising mixing an active ingredient/polymer solution or precipitate with an aqueous solution of a polymeric coating material continuously in a mixing chamber by spraying the two components as a compact jet into a mixing chamber,

wherein said polymeric coating material is selected from the group consisting of gelatin, chitosan, alginates, casein, caseinates, and homopolymers of acrylic acid,

wherein the particle size of the core/shell structure is in the range of 0.05 to 0.9 and

wherein the coating matrix of the nanoparticulate preparation comprises polymeric peptides.

6. A process for preparing a nano-particulate re pharmaceutical or cosmetic metic active ingredient with a core/shell structure, in which an X-ray amorphous active ingredient is present in the core together with one or more copolymers of acrylates, methacrylates, methacrylic acid or acrylic acid, and the shell consists of a stabilizing coating matrix,

the process comprising mixing an active ingredient/polymer solution or precipitate with an aqueous solution of a polymeric coating material continuously in a mixing chamber by spraying the two components as a compact jet into a mixing chamber,

wherein said polymeric coating material is selected from the group consisting of gelatin, chitosan, alginates, casein, caseinates, and homopolymers of acrylic acid,

wherein the particle size of the core/shell structure is in the range of 0.05 to 0.9 μm, and

wherein the preparation comprises gelatin as coating polymer.

7. A process for preparing a nano-particulate preparation of a pharmaceutical or cosmetic active ingredient with a core/shell structure, in which an X-ray amorphous active ingredient is present in the core together with one or more copolymers of acrylates, methacrylates, methacrylic acid or acrylic acid, and the shell consists of a stabilizing coating matrix,

the process comprising mixing an active ingredient/polymer solution or precipitate with an aqueous solution of a polymeric coating material continuously in a mixing chamber by spraying the two components as a compact jet into a mixing chamber,

wherein said polymeric coating material is selected from the group consisting of gelatin, chitosan, alginates, casein, caseinates, and homopolymers of acrylic acid,

wherein the particle size of the core/shell structure is in the range of 0.05 to 0.9 μm, and

wherein the preparation comprises casein or sodium caseinate as coating matrix.

8. The process as claimed in claim 1 , wherein the process produces a hydrosol of the said nanoparticulate preparation.

9. The process as claimed in claim 8 , in which wherein the sizes of the hydrosol nanoparticles increase by less than 50% in the first hour after preparation of the hydrosol.

10. The process for producing preparations as claimed in claim 1 , further comprising

preparing a solution of the active ingredient in an organic solvent which is at least 10% by weight miscible in water,

mixing this solution with the core polymer or a solution of the core polymer in an organic solvent, and

bringing the resulting mixture into contact with an aqueous solution of the coating polymer.

11. A nanoparticulate preparation of a pharmaceutical or cosmetic active ingredient with a core/shell structure

wherein an X-ray amorphous active ingredient is present in the core together with one or more polymers selected from the group consisting of copolymers of acrylates, methacrylates, methacrylic acid and acrylic acid,

wherein the shell consists of a stabilizing coating matrix,

wherein said polymeric coating material is selected from the group consisting of gelatin, chitosan, alginates, casein, caseinates, and homopolymers of acrylic acid,

wherein the particle size of the core/shell structure being in the range of 0.05 to 0.9 μm,

wherein the core of the preparation has at least two separate phases, and

wherein the nanoparticulate preparation is obtained by mixing an active ingredient/core polymer solution or precipitate with the an aqueous solution of the polymeric coating material continuously in a mixing chamber.

12. The preparation of claim 11 , wherein on redissolving, the preparation has the same particle size distribution, with a variation of 20%, as the initial preparation.